Empagliflozin/Linagliptin clinical trials
How each study uses Empagliflozin/Linagliptin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Glyxambi film-coated tablets
- 2
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Humanis Saglık Anonim Sirketi (2) · Institut für Pharmakologie und Präventive Medizin (1)
Often tested with
Tested in the same studies.
Empagliflozin (1) · Linagliptin (1) · Metformin (1) · Insulin (1)
Related medicines
As reviewed, each with the page that says it.
- One of DPP-4 inhibitors source
- One of Protease Inhibitors source
- One of SGLT2 inhibitors source
Studies
Open first, then newest update. How each study uses Empagliflozin/Linagliptin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.CompletedPhase 1Humanis Saglık Anonim SirketiNCT07039890Written as Glyxambi film-coated tablets
- Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated TabletsCompletedPhase 1Humanis Saglık Anonim SirketiNCT06932159Written as Glyxambi film-coated tablets
- Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesCompletedPhase 3Institut für Pharmakologie und Präventive MedizinNCT02752113Written as Empagliflozin and Linagliptin